Valeant Pharmaceuticals International (VRX) announced a public offering of its common shares to raise gross proceeds of approximately $1.75 billion after the close Monday. The stock is now down 0.82 on 16K shares.
Valeant Pharmaceuticals traded in a range for the majority of Monday's session and closed up by 0.62 at $84.82. The stock has been moving in a narrow range for the last 2 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.